Rapid Influenza Diagnostics Market Trends

Growth Drivers

• Escalating Technological Advancements – Rapid molecular testing is a new type of highly sensitive and specific molecular diagnostic test for influenza diagnosis that has emerged in recent years. The ability to identify respiratory viruses has been significantly improved through the use of RT-PCR and nucleic acid labeling detection tests. Furthermore, the fundamental goal of molecular influenza diagnostics is to identify specific known pathogens using NAT. NAT is superior to other existing diagnostic devices in several aspects. They do not impact the survival of the target bacteria and can provide results within a clinically relevant time frame. They are capable of identifying low numbers of all known influenza viruses in clinical samples.
• Increasing Awareness about the Advantages of Early Diagnosis - Another factor driving the need for rapid diagnostic testing for influenza is the growing understanding of the importance of early identification of viral diseases in the global population. In an effort to reduce or even eliminate disease-related mortality, organizations are implementing initiatives to encourage early detection. Make it important the medical decisions regarding support and treatment are made easier due to early diagnosis, for both patients and medical staff. Receiving a proper diagnosis as soon as possible after recognizing the cognitive symptoms associated with the medical condition has many benefits.

Challenges

• Variability in Test Sensitivity and Specificity – The sensitivity and specificity of rapid influenza diagnostic tests can vary depending on the type of test and the virus strain being tested. This can lead to false-positive and false-negative results. This is expected to hamper the market expansion of the rapid influenza diagnostics market in the upcoming time period.
• High Cost of Development and Commercialization is Set to Restrict Market Expansion in the Future Times.
• Strict Regulatory Requirements are Expected to Hamper the Market Growth in the Forecast Time Period.